The Executive Director, Global Commercial Strategy (GCS) Kidney will be the senior commercial leader for povetacicept across kidney indications, including immunoglobulin A nephropathy (IgAN) and primary membranous nephropathy (pMN). The role owns the global commercial strategy for the kidney franchise, supporting the near-term U.S. launch and subsequent global launches in IgAN while advancing pMN toward commercialization. The Executive Director will co-lead the povetacicept Kidney Program Team with the Development Lead, guiding program strategy and key development, lifecycle, and investment decisions. The role leads global launch execution and lifecycle management in IgAN and builds the global commercialization and launch strategy for pMN. The position also builds and leads a high-performing kidney commercial team and partners across functional and regional teams to deliver a globally aligned strategy and launch plan.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Executive